Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07345130 · ClinicalTrials.gov registry record · Phase 1
A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions
A Phase 1 study, sponsored by HALEON.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
NCT07345130 is a Phase 1 study that has completed, run by HALEON. The registered enrollment target is 50 participants.
The verdict
NCT07345130, a Phase 1 study, has completed, sponsored by HALEON.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the bioequivalence of Advil Tablet (Mini) (Test Product) to Advil Tablet (Reference Product) under fasted conditions and to characterize the impact of food on the bioavailability of the Test Product under fed conditions.
Interventions
- DRUG Advil Tablet (Mini) (Test Product)
- DRUG Advil Tablet (Reference Product)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-12-17 |
| Est. Completion | 2026-02-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07345130
The ClinicalTrials.gov registry entry for NCT07345130 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HALEON, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Advil Tablet (Mini) (Test Product) is the first listed.
NCT07345130 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07345130 about?
NCT07345130 is a clinical study titled "A Bioequivalence Study of Advil Tablet (Mini) (Ibuprofen 200 mg) Versus Advil Tablet (Ibuprofen 200 mg) in Healthy Adult Subjects Under Fasted Conditions and Bioavailability Assessment of Advil Tablet (Mini) Under Fed Conditions". The purpose of this study is to assess the bioequivalence of Advil Tablet (Mini) (Test Product) to Advil Tablet (Reference Product) under fasted conditions and to characterize the impact of food on the bioavailability of the Test Product under fed conditions.
What is the current status of trial NCT07345130?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2025-12-17. Estimated completion is 2026-02-03.
What interventions are being tested in trial NCT07345130?
The interventions under investigation include: Advil Tablet (Mini) (Test Product) (DRUG), Advil Tablet (Reference Product) (DRUG).
Who is sponsoring clinical trial NCT07345130?
This trial is sponsored by HALEON, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.